medigraphic.com
ISSN 0016-3813 (Print)

2019, Number 4

<< Back Next >>

Gac Med Mex 2019; 155 (4)

De vuelta a la clínica. Métodos I. Diseños de investigación. Mayor calidad de información, mayor certeza a la respuesta

Talavera JO, Roy-García I, Palacios-Cruz L, Rivas-Ruiz R, Hoyo I, Pérez-Rodríguez M

Language: Spanish
References: 32
Page: 399-405
PDF size: 150.93 Kb.


ABSTRACT

Research designs refer to the way information is obtained and are limited by ethical, economic and temporal viability. Research designs are standardized strategies to reduce biases, which in the architectural model of research are identified in the baseline state, the maneuver and the outcome; hence, there are no specific designs for each question. The design with the lowest probability of bias is the clinical trial, followed by cohort and case-control studies and, finally, by cross-sectional surveys. Among the main characteristics that give merit to research designs are the following: population inquiry, which refers to the situation of the population in relation to the clinical course/natural history of the disease; the maneuver, or action that is expected to modify the baseline state, which can be observational or experimental; follow-up, or documented monitoring that is given to each subject, which can be longitudinal or cross-sectional; and directionality, which can prolective or retrolective and refers to the timing of data collection for research purposes. It will always be better having a valuable question, even when answered with a design with higher risk of bias, than a question that is irrelevant or has no applicability.


REFERENCES

  1. Talavera JO. Research designs. Rev Med Inst Mex Seguro Soc. 2013;51:S10-S15.

  2. Hernández-Sampieri R. Metodología de la investigación. México: Mc- Graw Hill; 2014.

  3. Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21:125-127.

  4. Ernster VL. Nested case-control studies. Prev Med. 1994;23:587-590.

  5. Rivas-Ruiz R, Clark P, Talavera JO, Huitrón G, Tamayo JA, Salmerón J. Bone speed of sound throughout lifetime assessed with quantitative ultrasound in a Mexican population. J Clin Densitom. 2015;18:68-75.

  6. Talavera JO, Wacher-Rodarte NH, Rivas-Ruiz R. Investigación clínica III. Estudios de causalidad. Rev Med Inst Mex Seguro Soc. 2011;49:289-294.

  7. ASCEND Study Collaborative Group, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, et al. Effects of n-3 fatty acid supplements in diabetes mellitus. N Engl J Med. 2018;379:1540-1550.

  8. Salminen P, Paajanen H, Rautio T, Nordström P, Aarnio M, Rantanen T, et al. Antibiotic therapy vs appendectomy for treatment of uncomplicated acute appendicitis: the APPAC Randomized Clinical Trial. JAMA. 2015;313:2340-2348.

  9. Méndez-Hernández P, Flores Y, Siani C, Lamure M, Dosamantes-Carrasco LD, Halley-Castillo E, et al. Physical activity and risk of metabolic syndrome in an urban Mexican cohort. BMC Public Health. 2009;9:276.

  10. Diez-Ruiz A, Bueno-Errandonea A, Núñez-Barrio J, Sánchez-Martín I, Vrotsou K, Vergara I. Factors associated with frailty in primary care: a prospective cohort study. BMC Geriatr. 2016;28:91.

  11. Ventura-Ríos L, Bañuelos-Ramírez D, Hernández-Quiroz-MC, Robles-San Román M, Irazoque-Palazuelos F, Goycochea-Robles MV. Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0. Reumatol Clin. 2012;8:189-194.

  12. Machado AD, Anjos FSND, Domingos MAM, Molina MDCB, Marchioni DML, Benseñor IJM, et al. Dietary intake of non-dialysis chronic kidney disease patients: the PROGREDIR study. A cross-sectional study. Sao Paulo Med J. 2018;136:208-215.

  13. Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn’s disease. Scand J Gastroenterol. 2009;44:446-456.

  14. Gallegos-Carrillo K, Flores YN, Denova-Gutiérrez E, Méndez-Hernández P, Dosamantes-Carrasco LD, Henao-Morán S, et al. Physical activity and reduced risk of depression: results of a longitudinal study of Mexican adults. Health Psychol. 2013;32:609-615.

  15. Pacheco NL, Andersen AM, Kamper-Jørgensen M. Preeclampsia and breast cancer: the influence of birth characteristics. Breast. 2015;24: 613-617.

  16. Talavera JO, Rivas-Ruiz R. Investigación clínica IX. Del juicio clínico al ensayo clínico. Rev Med Inst Mex Seguro Soc. 2013;51:S58-S63.

  17. Talavera JO, Rivas-Ruiz R. Investigación clínica X. Del juicio clínico al diseño de cohorte. Rev Med Inst Mex Seguro Soc. 2013;51:S64-S69.

  18. Reynoso-Noverón N, Villarreal-Garza C, Soto-Pérez de Celis E, Arce-Salinas C, Matus-Santos J, Ramírez-Ugalde MT, et al. Clinical and epidemiological profile of breast cancer in Mexico: results of the Seguro Popular. J Glob Oncol. 2017;3:757-764.

  19. Briseño-Bass P, Chávez-Pérez R, López-Zendejas M. Prevalence of liver steatosis and its relation to liver function tests and lipid profile in patients at medical check-up. Rev Gastroenterol Mex. 2018;3:S0375-S0906.

  20. Cantoral A, Téllez-Rojo MM, Ettinger AS, Hu H, Hernández-Ávila M, Peterson K. Early introduction and cumulative consumption of sugar- sweetened beverages during the pre-school period and risk of obesity at 8-14 years of age. Pediatr Obes. 2016;11:68-74.

  21. Cacho-Díaz B, Spínola-Maroño H, Reynoso N, González-Aguilar A, Mohar-Betancourt A. Role of overweight, obesity, and comorbidities in the prognosis of patients with breast cancer with brain metastases. Clin Breast Cancer. 2019;19:394-398.

  22. Espiritu AI, Mesina BVQ, Puerto AAD, Reyes NGD, Damian LF, Pascual V JLR. Neuromyelitis optica spectrum disorder in a tertiary hospital in the Philippines: a case series. Mult Scler Relat Disord. 2019;31: 124-130.

  23. Abdelmabood S, Fouda AE, Boujettif F, Mansour A. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival. J Pediatr (Rio J). 2018;S0021-7557:30583-30587.

  24. Lepe-Zúñiga JL, Méndez-Cigarroa AO, Jerónimo-López FJ, Hernández- Orantes JG. [Sobrevida global de pacientes con leucemia aguda en el Hospital de Especialidades Pediátricas de Chiapas, México]. Bol Med Hosp Infant Mex. 2018;75(6):338-351.

  25. Talavera JO, Rivas-Ruiz R. From clinical judgment to case-control design. Rev Med Inst Mex Seguro Soc. 2013;51:S70-S75.

  26. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. Br Med J. 1952;2:1271-1286.

  27. Girma S, Fikadu T, Abdisa E. Maternal common mental disorder as predictors of stunting among children aged 6-59 months in western Ethiopia: a case-control study. Int J Pediatr. 2019;2019:4716482.

  28. Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019;6:427-436.

  29. Hodge SE, Subaran RL, Weissman MM, Fyer AJ. Designing case-control studies: decisions about the controls. Am J Psychiatry. 2012;169:785-789.

  30. Blaser L, Hassna H, Hofmann S, Holbro A, Haschke M, Zeller A, et al. Leucopenia associated with metamizole: a case-control study. Swiss Med Wkly. 2017;147:w14438.

  31. Talavera JO, Rivas-Ruiz R. From clinical judgment to cross-sectional survey. Rev Med Inst Mex Seguro Soc. 2013;51:S76-S79.

  32. Shigdel R, Stubbs B, Sui X, Ernstsen L. Cross-sectional and longitudinal association of non-exercise estimated cardiorespiratory fitness with depression and anxiety in the general population: the HUNT study. J Affect Disord. 2019;252:122-129.




2020     |     www.medigraphic.com